Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia. - Wikidata - wikimedia - TriplyDB

Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.

Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.

http://www.wikidata.org/entity/Q35054548

about

The dopamine d1-d2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in Basal Ganglia Molecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric Disorders Brain-derived neurotrophic factor epigenetic modifications associated with schizophrenia-like phenotype induced by prenatal stress in mice.BDNF deficiency and young-adult methamphetamine induce sex-specific effects on prepulse inhibition regulation.Is lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses.Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice.Brain-derived neurotrophic factor (BDNF) Val(66)Met polymorphism differentially predicts hippocampal function in medication-free patients with schizophrenia.Genetic and epigenetic regulation of the brain-derived neurotrophic factor in the central nervous system.Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders DNA-methylation gene network dysregulation in peripheral blood lymphocytes of schizophrenia patients.Paranoid schizophrenia is characterized by increased CB1 receptor binding in the dorsolateral prefrontal cortex Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis.Genetic evidence for the association between the early growth response 3 (EGR3) gene and schizophrenia Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia: A systematic review Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction Increases in [3H]muscimol and [3H]flumazenil binding in the dorsolateral prefrontal cortex in schizophrenia are linked to α4 and γ2S mRNA levels respectively.Neurodevelopment, GABA system dysfunction, and schizophrenia Modeling the molecular epigenetic profile of psychosis in prenatally stressed mice.Genetics and function of neocortical GABAergic interneurons in neurodevelopmental disorders Peripheral BDNF: a candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia.The NMDA receptor co-agonists, D-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex.Increases in two truncated TrkB isoforms in the prefrontal cortex of people with schizophrenia Reciprocal Alterations in Regulator of G Protein Signaling 4 and microRNA16 in Schizophrenia Functional Role of BDNF Production from Unique Promoters in Aggression and Serotonin Signaling.Dopamine receptor homooligomers and heterooligomers in schizophrenia Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder.Neurotrophin signalling: novel insights into mechanisms and pathophysiology.Is altered BDNF biosynthesis a general feature in patients with cognitive dysfunctions?DNA methylation of the BDNF gene and its relevance to psychiatric disorders.Toward the identification of peripheral epigenetic biomarkers of schizophrenia.DNA methylation and demethylation as targets for antipsychotic therapy.Brain-Derived Neurotrophic Factor Expression in Individuals With Schizophrenia and Healthy Aging: Testing the Accelerated Aging Hypothesis of Schizophrenia.Expression and methylation of BDNF in the human brain in schizophrenia.Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia.Robust changes in expression of brain-derived neurotrophic factor (BDNF) mRNA and protein across the brain do not translate to detectable changes in BDNF levels in CSF or plasma.Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments.Altered CREB Binding to Activity-Dependent Genes in Serine Racemase Deficient Mice, a Mouse Model of Schizophrenia.Sex-specific disruptions in spatial memory and anhedonia in a "two hit" rat model correspond with alterations in hippocampal brain-derived neurotrophic factor expression and signaling.DNA methylation pattern of gene promoters of major neurotransmitter systems in older patients with schizophrenia with severe and mild cognitive impairment.A Novel Ultrasensitive In Situ Hybridization Approach to Detect Short Sequences and Splice Variants with Cellular Resolution.

P2860

Q21131063-1ED181A5-FF72-4C48-AD04-29C2DE716ED8 Q26766487-D7159EE6-6844-4D6E-BBF8-8CC5B56987EC Q30416726-677905BF-6B6F-4124-BFD7-0BE39DE13E76 Q30453396-C5B3933F-20C8-49B2-925E-EFF3C6211895 Q30454141-0C3C03F5-9687-4776-9646-1FFA9405D77B Q30465290-D70A7283-5545-4E62-9DF5-59C873DE508D Q30586016-D629FA5D-A228-4A26-8704-D0CD7ADCCE1F Q33653087-4A662C7C-F145-4F93-9DB4-49FEC0875628 Q33672712-CA3226D7-8289-480D-8954-5D405152987F Q34002660-42D149DA-3769-402E-875D-CE255428E5B5 Q34026425-0A945514-0B4B-4EE7-A658-3B435175CD9F Q34132832-35B376FC-F90C-4DA2-84B0-3EAF18249573 Q34140405-99D18353-21E8-4730-8FAC-F7E76D5C0120 Q34347464-2BD30C1B-0C4D-4937-B6E8-2C6A5DF1DDD7 Q34348224-20E1F381-3575-498B-8AAD-6874AF0857D3 Q34548202-F21A5062-A9EA-4070-86C0-FCAB0FC99300 Q34675943-5BBD021A-B1A8-4D2A-AAA0-7B5ABD7F7A08 Q34815864-5E0B2495-7000-4F8A-8DD2-040DA031B7A3 Q35173644-C9B94FCF-FCBE-416D-B2F3-7D941DB234F6 Q35550864-26EF3426-6FB3-4888-9FE0-658AC8CA82E1 Q35675159-BEBE212D-1B3B-48C6-ACCD-DE8F080718A2 Q36471519-5222F582-797C-4204-836E-67491100993C Q36580028-35EC119C-9349-45F6-8BD6-8522025A00C0 Q37006269-CFE88C77-958B-4A4B-A08C-E345FC4F1DC8 Q37242424-C2E6AB2C-5B63-4CF3-AE2A-861250B3A773 Q37621319-268C4463-B9B6-477C-87EA-B9B6F40F73F3 Q37629100-93759D1F-AD99-4761-8956-3D3919A27C80 Q38067671-EAD126F2-B6EB-4F8B-A45F-34BC657F3328 Q38112245-3A8DCFAE-A9A1-4F3B-8A17-8E5AD5AE6527 Q38202190-31ACBE0E-E597-4C51-A91F-E174A731D867 Q38264416-AFCCD681-30D7-4322-8BEB-426E73C437E1 Q38769563-D5A5F109-3BA4-495B-97B6-2453D1C5744C Q39315740-CD39987B-C1F3-43C2-B1F7-A2298FCAA51D Q43444866-904761D0-F420-4EAC-889C-459273DDE552 Q44669549-C25FAF20-FECF-44E1-A227-ADF2E1661059 Q47135096-2E53D7C7-B64F-407A-A731-A75141B7B298 Q47367883-376B9D9C-57B1-4179-A0B9-6074F07A2422 Q47879222-648EA8B3-FFA6-4C1E-92AE-490B49BF41C6 Q48648416-158AE3B8-42F7-4AFF-8E08-4494D125F152 Q49629866-CB28E705-688F-452C-A159-526CCF9DFB4B

P2860

Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.

http://www.wikidata.org/entity/Q35054548

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.

@ast

Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.

@en

type

label

Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.

@ast

Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.

@en

prefLabel

Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.

@ast

Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.

@en

P1433

Q35054548-6D0E244E-95DF-4B5B-8992-F045068BFCB0

P1476

Q35054548-1AE9BD0D-342B-449B-8287-AF2E416C9EED

P2093

Q35054548-2C34AE49-B646-462D-B499-AD3584D784BB

Q35054548-37BED89E-7FF2-4058-A935-9115B80693A3

Q35054548-A61D2BB5-5D4E-4F71-9539-539F41F36A67

Q35054548-BA3678D1-4963-4208-8369-F1CAE7940916

Q35054548-DC01805B-C533-4E9E-A44C-A381C94E9C0C

Q35054548-FD179FBA-5DC8-41AE-AB82-A3028C0267E1

P2860

Q35054548-01B63234-34BD-485F-8C3A-86DB4AF69A91

Q35054548-0739D766-2C23-4CD5-9CAF-FC82D50DD3EA

Q35054548-08459A94-33F8-4866-826D-E6E97B593F3A

Q35054548-099B8D8D-16A0-4DBE-ABBD-4CDD4366FAE2

Q35054548-0BE217B1-104E-4234-A5F7-F836C6FF97B8

Q35054548-0F740962-7C2B-4432-BB15-4F61D552C614

Q35054548-14DB1779-FB0E-463A-9F27-53EDC0DCF8C1

Q35054548-167E866F-5073-4729-984E-9AC5242EF243

Q35054548-1FD24C03-4067-47D0-96B3-2863A5BB6907

Q35054548-20CA5267-2551-4CD9-9FEA-D2A0E8C8A9FC

P304

Q35054548-ED23F8E2-1AA0-4FE6-90AC-9BFEF5B25B64

P31

Q35054548-BC1BE26B-FE8D-4B02-BEBE-A25C5661BB04

P356

Q35054548-47946AD3-E749-49B7-BBEB-43B4EF860AC7

P407

Q35054548-3981A0FE-9588-494B-8087-F4FD3542E703

P433

Q35054548-6040917E-5942-4C35-9EC5-9D39CD5244B1

P478

Q35054548-519958E6-9D0A-4537-9BA0-EB4E6ECA8FA8

P577

Q35054548-BC810461-53E8-4E72-8DB4-1A5E1050C731

P5875

Q35054548-9E29403C-995F-4A16-9CDF-A68B0AE86202

P698

Q35054548-94F789E5-7043-4386-8897-3E2FA5A6B8AF

P921

Q35054548-8BA77CF2-6476-4450-A776-CEC934317EBF

P932

Q35054548-780BF25A-4204-4FA9-AB22-E53625791A20

P356

J.NEUROSCIENCE.2010.05.037

P1433

P1476

Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.

@en

P2093

A Deep-Soboslay

http://www.w3.org/2001/XMLSchema#string

C Shannon Weickert

http://www.w3.org/2001/XMLSchema#string

H L Cassano

http://www.w3.org/2001/XMLSchema#string

J E Kleinman

http://www.w3.org/2001/XMLSchema#string

J Wong

http://www.w3.org/2001/XMLSchema#string

T M Hyde

http://www.w3.org/2001/XMLSchema#string

P2860

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

Brain-derived neurotrophic factor: role in depression and suicide

Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites

Cell biology of the hippocampal formation in schizophrenia.

The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Selection of reference gene expression in a schizophrenia brain cohort.

Chlorpromazine equivalent doses for the newer atypical antipsychotics.

Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in rats.

Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone.

Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders.

P304

1071-1084

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROSCIENCE.2010.05.037

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

169

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44678711

http://www.w3.org/2001/XMLSchema#string

P698

20553817

http://www.w3.org/2001/XMLSchema#string

P921

P932

3118308

http://www.w3.org/2001/XMLSchema#string